|
This page contains a list of articles published at www.genericsweb.com and in our e-newsletter INNsight (click here to register). Browse the list below for articles of interest or search our archives.
You can also consult the entire list of Drug In Focus articles, analysing patent protection on over 30 molecules including Atorvastatin, Venlafaxine, Rosiglitazone, Famciclovir, Ropinirole and many more.
|
| |
| Patent Searching and IP Management |
|
| Patent protection |
|
| Litigation |
|
| Markets |
|
| Legislation and litigation |
| IP Strategy |
|
| Paragraph IV |
|
| Licensing |
|
| SPCs |
|
| |
|
| Patent Searching and IP Management - GenericsWeb |
| 22/02/10 |
Infringement of Process Patents in Australia. The vexed case of intermediates |
| 22/01/10 |
How to Calculate Expiry Dates and Data Exclusivity in Key Territories |
| 03/02/08 |
When does the patent expire? |
| 01/04/07 |
Use of patents in drug lifecycle management |
| 01/01/07 |
The changing face of patents in generic pharmaceutical development: Facts and figures |
| 20/07/06 |
Generic Pharmaceutical Patent Searching I: Getting the info you need |
| 19/06/06 |
Generic Pharmaceutical Patent Searching II: Managing your patent info |
| 20/09/05 |
How to Avoid Patent Infringement in Developing APIs and Generics
(Click here for Chinese version) |
| d |
|
| Patent protection - GenericsWeb |
| 15/06/09 |
Strategic use of Supplementary Protection Certificates |
| 11/11/08 |
The practicalities of paediatric extensions to the Supplementary Protection Certificate |
| 15/07/08 |
Formulation patents in pharmaceutical development |
| 15/04/08 |
Molecular form: Patentability of known active ingredients |
| 15/12/07 |
Tolterodine Polymorph Patent Highlights Ongoing Quality Issues in USPTO |
| 01/05/07 |
Fluvastatin and Atorvastatin: A comparison of patent protection (Part 1) |
| 01/08/07 |
Fluvastatin and Atorvastatin: A comparison of patent protection (Part 2) |
| 17/05/07 |
Alendronate Once-A-Week Formulation Patent Threat Still Alive in Australia |
| 26/03/07 |
Levitra® - Opportunity for Proactive Generic Companies? |
| 02/02/07 |
Esomeprazole Remains Under Threat |
| 26/04/06 |
Full Story of Relpax Patent Protection Not Told by Orange Book? |
| 05/08/06 |
Avandia Patents Afford Protection Against Generic Competition |
| 10/11/06 |
More to Veterinary Anthelmintic ProHeart® than Green Book Indicates |
| . |
. |
| Litigation |
| 15/08/10 |
Some litigation practice issues for generic pharma in Australia |
| 15/08/10 |
Pay for Delay – The State of the Law |
| 15/07/10 |
Epidemiology: The First Defense to Pharmaceutical Products Liability Actions |
| 15/06/10 |
A Proposal to Curb Misuse of ‘Exceptional Case’ Allegations Against ANDA Applicants |
| 15/05/10 |
U.S. Court Extends Long-Arm Jurisdiction to Foreign Manufacturers |
| 15/05/10 |
Delaying Generic Drugs: The Legal Landscape Surrounding Reverse Payment Agreements To Protect Patent Holders |
| 15/04/10 |
Sanctioning ANDA Plaintiffs For Poor Behavior |
| 15/03/10 |
False Marking Claims in the U.S.: Different Kind of Patent Litigation |
| 15/02/09 |
Courts Are Divided on Whether Failure to Warn Claims Against Generic Drug Manufacturers Can Be Preempted |
| 10/11/08 |
United States: Even After Patent Has Expired, District Court Has Jurisdiction To Set Exclusivity Date |
| 10/03/08 |
Favourable patent decision for research based pharma in Spain |
| 15/01/08 |
An early route to market for generics? |
| 15/08/07 |
Arrow points towards clarity: Arrow V Merck - Alendronate again... |
| 15/06/07 |
More about parallel imports - Boehringer V Swingward |
| 10/06/07 |
Canada: generic manufacturers may not be required to address all listed patents |
| 01/06/07 |
Generics Emboldened in Australia |
| 15/04/07 |
Parallel importation |
| 14/01/07 |
Angiotech, Conor - not so obvious |
| 10/11/06 |
Scottish Polymorphs |
| 03/10/06 |
Interlocutory Injunctions |
| 20/08/06 |
Mayne v Debiopharm |
|
| 03/10/06 |
Interlocutory Injunctions |
| 13/07/06 |
IVAX v Chugai |
| 16/05/06 |
Patented medicines for developing countries |
| 10/03/06 |
Patent term extensions in Australia |
| 01/03/06 |
Paediatric use - proposed regulation |
| 10/02/06 |
Bolar Provision: A global history and the future for Europe |
| 01/02/06 |
John Woolfe’s impact on crucial outcomes for the generics industry |
| 01/01/06 |
Contracts: avoiding the pain |
| 01/12/05 |
Directive 2004/27/EC – New European Data Exclusivity Provisions |
| 29/09/05 |
SPCs - when can they be granted? |
| 30/08/05 |
Injunctions and Cross-undertakings |
| 30/07/05 |
Patent Revocation |
| 30/06/05 |
AstraZeneca - Abuse of Dominant Position |
| 31/05/05 |
Data Protection: High Court Allows Registration of Alendronate 70mg |
| 30/03/05 |
Multi-party Actions - Who Pays The Costs? |
| 30/04/05 |
Mayne Pharma V Pharmacia, Servier V Niche Generics |
| . |
. |
| Markets |
|
| 15/07/10 |
Big Pharma swallows the Generic medicine |
|
| 15/06/10 |
Europe swings the pricing axe |
|
| 15/04/10 |
Biosimilars – A US regulatory mechanism at last |
|
| 15/03/10 |
The Race for Ratiopharm |
|
| 15/01/10 |
CPhI India - how does it compare? |
|
| 15/10/09 |
CPhI - has it grown too big? |
|
| 15/09/09 |
Illegal generics |
|
| 15/07/09 |
US Biosimilars |
|
| 15/06/09 |
A sinister conspiracy? |
|
| 15/04/09 |
Big Pharma Vs Generics |
|
| 15/01/09 |
Roll up, roll up; companies for sale |
|
| 15/11/08 |
The FDA gets tough |
|
| 15/10/08 |
How to make more money by not launching |
|
| 16/08/08 |
Star wars – The generic empire strikes back |
|
| 15/04/08 |
The Japanese (generic) puzzle |
|
| 15/03/08 |
Teva – generic world champion as a model of evolution? |
|
| 15/12/07 |
AstraZeneca - on the ropes? |
|
| 15/11/07 |
Biosimilars - breaking through at last? |
|
| 15/08/07 |
The German Drug Reforms – a fatal blow to the German industry? |
|
| 15/06/07 |
The China Syndrome - regulatory meltdown? |
|
| 10/05/07 |
Merck Generics – the consolidation continues (again!) |
|
| 15/03/07 |
The continuing battle over Lipitor |
|
| 10/01/07 |
Biosimilars - inflated expectations? |
| 12/11/06 |
Germany - rising costs |
| 15/11/06 |
Spain - a work in progress |
| 12/10/06 |
The consolidation continues - part II |
| 10/05/06 |
Generics as R&D experts |
| 12/06/06 |
The story so far |
| 10/05/06 |
US generics - evolution or revolution? |
| 10/04/06 |
European generics - steaming ahead or grinding to a halt? |
| 01/03/06 |
Authorised generics - what are they? |
| 01/02/06 |
Asia – the next big thing in generics – but at what price? |
| 01/01/06 |
A shaky future for US companies? |
| 01/12/05 |
CPhI then and now |
| 25/09/05 |
Generics then and now |
| 28/08/05 |
Teva - a case study |
| 27/07/05 |
The consolidation continues |
| 26/05/05 |
Europe - The generics pricing squeeze |
| 25/04/05 |
Europe - The North-South divide |
| 14/03/05 |
Generics superheroes |
|
| 28/02/05 |
A Passage to India? |
|
|
| . |
. |
|
| Legislation and litigation |
|
|
| 08/11/09 |
Biosimilars Provision Included In House Health Care Reform Bill |
|
| 25/10/09 |
Pharma Industry Under Antitrust Scrutiny |
|
| 15/09/09 |
Obvious (not) to try - the Calcipotriol Monohydrate Case |
| 15/08/09 |
Antitrust sanctions for litigation dirty tricks? |
| 15/07/09 |
Levofloxacin Patent and SPC upheld on appeal |
| 15/06/09 |
Australian: Patent Term Extension Available If Has Pharmaceutical Characteristics |
|
| 15/05/09 |
EPO gets tough on applicants - The changes. |
|
| 20/04/09 |
Memantine, new rights for old drugs? |
| 15/02/09 |
Pain Relief for Generics in UK Infringement case |
| 15/12/08 |
Patentee Cleans up in Anti-infective Enantiomer Patent Case |
| 19/08/08 |
The issues in the UK Olanzapine case |
| 18/05/08 |
UK Escitalopram appeal judgment - frequently asked questions |
| 15/04/08 |
Escitalopram enantiomer patent claims upheld in court |
| 10/03/08 |
Obvious Combinations |
| 16/02/08 |
Pharmaceutical Sector Inquiry |
| 24/01/08 |
United States: Follow-On Biologics And Patent Reform |
| 15/07/07 |
Apotex blows a hole in Perindopril patent thicket |
| 10/05/07 |
UK Enantiomeric form patent held non-obvious but invalidated for insufficiency. |
| 16/03/07 |
Paediatric Regulation - what it means for the generics industry |
|
| 01/09/06 |
Follow-on Biologics legislation |
|
|
d. |
|
|
| IP Strategy |
| 18/02/10 |
Satisfying the Requirements for Industrial Applicability - England & Wales Court of Appeal Provides Guidance For Biotech Inventionson |
| 08/01/10 |
European Harmony on Selection Patents |
| 15/08/07 |
Pharmaceutical & Biotech Lifecycle Management (II) |
| 15/07/07 |
Lifecycle Management (I) are generics launching earlier than ever? |
| 04/04/07 |
IP freedom to operate put simply |
| 02/12/07 |
Lilly wins Zyprexa |
| 10/08/06 |
US Court of Appeal Lipitor judgement |
| 20/05/06 |
European Court of Justice SPC rulings |
| 15/07/06 |
Value for money in global patent litigation |
|
| . |
| Paragraph IV |
| 05/08/06 |
The Plavix Patent Case |
|
|
|
. |
|
|
| Licensing |
|
|
| 15/05/09 |
How to grow your generic business through licensing partnerships |
|
| . |
|
|
| SPCs |
|
| 10/06/07 |
SPC News |
| 01/07/06 |
Medicinal Product SPCs in Europe from 1991 to 2005 |
|
.. |
Home
Articles
Pipeline